These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17290462)

  • 21. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overestimation of stability limits leads to a high frequency of falls in patients with Parkinson's disease.
    Kamata N; Matsuo Y; Yoneda T; Shinohara H; Inoue S; Abe K
    Clin Rehabil; 2007 Apr; 21(4):357-61. PubMed ID: 17613577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease.
    Suzuki K; Miyamoto M; Miyamoto T; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
    Parkinsonism Relat Disord; 2009 Jan; 15(1):15-9. PubMed ID: 18359262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
    Kenangil G; Orken DN; Ur E; Forta H; Celik M
    Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and course of health-related quality of life in Parkinson's disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Herlofson K; Alves G
    Mov Disord; 2008 Jul; 23(10):1420-7. PubMed ID: 18512757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major depression and health-related quality of life in Parkinson's disease.
    Jones CA; Pohar SL; Patten SB
    Gen Hosp Psychiatry; 2009; 31(4):334-40. PubMed ID: 19555793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study of personality in Parkinson's disease: the influence of motor and non-motor factors].
    Leiva-Santana C; Monge-Argilés JA; Galván-Berenguer B
    Rev Neurol; 2007 Jul 1-15; 45(1):7-12. PubMed ID: 17620259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying fallers with Parkinson's disease using home-based tests: who is at risk?
    Lim I; van Wegen E; Jones D; Rochester L; Nieuwboer A; Willems AM; Baker K; Hetherington V; Kwakkel G
    Mov Disord; 2008 Dec; 23(16):2411-5. PubMed ID: 18942084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs of illness and care in Parkinson's disease.
    Korczyn AD
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):151-2. PubMed ID: 21109406
    [No Abstract]   [Full Text] [Related]  

  • 37. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].
    Martínez-Martín P; Carroza-García E; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2009 Jul 1-15; 49(1):1-7. PubMed ID: 19557692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
    Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
    Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.